Search results :

Goserelin

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: L02AE03

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6
Amenorrhoea 100% x
Hot flush 46% - 96% x x x x x x
Vaginal inflammation 1% - 75% 6% x x
Libido decreased 44% - 61% x x x x
Depression 3% - 54% 7% x x x
Diarrhoea 1.28% - 40% x x x x
Seborrhoeic dermatitis 26% - 52% x x x
Breast atrophy 33% - 42% x
Mood swings postmarketing, 56% - 60% x x x x x x
Acne postmarketing, 42% - 55% x x
Sexual dysfunction 15% - 21% x x x
Rectal haemorrhage 20% x x
Breast enlargement 15% - 18% x x x
Cystitis 16% x x
Libido increased 12% - 19% x
Sweating 4% - 45% 5% x x x
Pain 3% - 31% x x x
Dyspareunia 5% - 14% x x
Tumour flare 4% - 23% x x x
Oedema peripheral 2.56% - 34% x x x
Hirsutism 7% - 15% x x
Lower urinary tract symptoms 8% - 13% x x x
Nocturia 10% x
Constipation 1-10% - 12% x x x x
Asthenia 5% - 13% x x x
Gynaecomastia 1-5% - 8.3% x x x x x
Nausea 2% - 14% 6% x x x x
Proctitis 8% x x
Hair disorder 4% - 11% x x
Pelvic pain 5.7% - 22% 6% x x x x
Abdominal pain 0% - 11% 10% x x x
Rash 1% - 8% x x x x x x
Myalgia 3% - 11% x x
Haematuria 1.28% - 12% x x x
Dysmenorrhoea 1-10% - 7% 9% x x
Migraine 1-10% - 7% 4% x x x
Infection 0% - 13% x x x x
Uterine haemorrhage 6% 4% x
Application site reaction 6% x
Bone pain 5.7% - 6% x x x x x
Back pain 0% - 16% 7% x x x
Alopecia 1-10% x x x x x
Anxiety 1-10% x x x x
Arrhythmia 1-10% x x x
Arthralgia 1-10% x x x x x x
Bronchitis 1-10% x x x
Cough 1-10% x
Dyspepsia 1-10% x x x x
Oedema 0% - 8% x x x x
Epistaxis 1-10% x x x
Flatulence 1-10% x x x
Gout 1-10% x x x
Haemorrhage 1-10% x x x
Hypersensitivity 1-10% x x x x
Hypertension postmarketing, 1-10% - 12% 2% x x x x x x
Arthropathy 1-10% x x x
Hypertonia 1% - 10% x x
Tachycardia 1-10% x x x
Ulcer 1-10% x x x
Weight increased 3% - 23% x x x x x
Dry mouth 1-10% x x x
Peripheral vascular disorder 1-10% x x x
Chills 1-10% x x x
Nervousness 3% - 5% 3% x x x
Pharyngitis 2% - 6% 9% x x
Vulvovaginitis 5% 1% x
Insomnia 1% - 16% x x x x
Upper respiratory tract infection 2% - 7% x x x
Lethargy 2% - 8% x x
Urinary tract infection 3.85% - 1-10% x x x x
Sinusitis 3% - 1-10% 6% x x x
Breast pain 2.56% - 7% x x x x
Dizziness 0% - 6% x x x x
Cramps of lower extremities 2% - 6% x x
Chronic obstructive pulmonary disease 3% - 5% x x x
Menorrhagia 4% 5% x x
Vomiting postmarketing, 4% - 7% x x x x
Anorexia 2% - 5% x x x x
Fatigue 2% - 5% x x x
Malaise 2% - 5% x x x
Increased appetite 2% - 5% x x x
Influenza 0% - 5% x x x
Cardiac failure congestive 1% - 5% x
Paraesthesia 1.27% - 1-10% x x x x x x
Erectile dysfunction 1.27% - 90% x x x x x
Urinary tract disorder 1.28% - 3.18% x x x x
Anaemia 0% - 1-10% x x x x
Dyspnoea 0% - 3.82% x x
Headache postmarketing, 0% - 75% 22% x x x x x
Pruritus 0% - 6% x x x
Reaction aggravation 0% - 3.18% x x
Pollakiuria 0% - 12% x x x x x
Sepsis 0% - 2.55% x x
Cough increased 0% - 2.55% x x x
Angina pectoris 0.637% - 1.28% x x
Bladder neoplasm 0.637% - 1.28% x x
Herpes simplex 0.637% - 1.28% x x
Cardiac failure 0% - 1.91% x x x x
Urination impaired 0% - 1.91% x x
Haematemesis 0% - 1.28% x x
Varicose vein 0% - 1.28% x x
Diabetes mellitus 0% - 1.27% x x x x x
Pneumonia 0% - 1.27% x x
Urinary incontinence 0% - 1.27% x x
Urinary retention 0% - 1.27% x x x
Cerebral ischaemia 0% - 1.27% x x
Transient ischaemic attack postmarketing x
Fracture postmarketing x x x
Hypercalcaemia postmarketing x x x
Hypotension postmarketing x x x x x x
Myocardial infarction postmarketing x x x x x x
Neoplasm postmarketing x x x x
Ophthalmoplegia postmarketing x x
Osteoporosis postmarketing x x x
Ovarian cyst postmarketing x x x x
Pituitary adenoma postmarketing, 1% x x x
Pituitary apoplexy postmarketing x x x
Pituitary tumour postmarketing x x x x
Psychotic disorder postmarketing x x x x
Pulmonary embolism postmarketing, 0% - 1.27% x x x
Convulsion postmarketing x x
Shock postmarketing x x
Cerebrovascular accident postmarketing, 0% - 1.27% x x x
Ovarian hyperstimulation syndrome postmarketing x x
Deep vein thrombosis postmarketing x x
Bone cancer metastatic postmarketing x
Mental state abnormal postmarketing x x
Pituitary infarction postmarketing x x
Change in blood pressure postmarketing x x x x
Amblyopia x x
Anaphylactic shock x x x x
Mental disorder x x
Blood pressure abnormal x x
Bone disorder x x
Breast disorder x x
Breast swelling x x
Chest pain x x
Confusional state x
Cyst x x
Drowsiness x
Drug hypersensitivity x x
Ecchymosis x x x
Endocrine disorder x x
Extravasation x
Eye disorder x
Body temperature increased x x x
Cardiac disorder x x
Hepatitis x
Herpes zoster x
Hypercholesterolaemia x
Hyperglycaemia x x
Hyperhidrosis x x
Hyperlipidaemia x
Immune system disorder x x
Incontinence x x
Infarction x x
Jaundice x
Leukopenia x x
Lymphoedema x x
Nervous system disorder x x
Nodule x
Palpitations x x
Polyp x x
Rhinitis x x
Spinal cord compression x x x x x
Swelling x
Thirst x
Thrombocytopenia x x
Thrombophlebitis x
Erythema x
Ureteric obstruction x x x x x
Urticaria x
Angiopathy x x
Vasodilation x
Sudden cardiac death x
Hepatic function abnormal x
High density lipoprotein decreased x
Injection site reaction x x x x x
Skin discolouration x x
Dry skin x x x
Degeneration of uterine fibroid x
Malnutrition x x
Photosensitivity reaction x
Unspecified disorder of skin and subcutaneous tissue x x
Thinking abnormal x x
Tenderness x x x
Galactorrhoea x
Condition aggravated x x
Muscle mass x
Testosterone low x x
Vaginal dryness x x x
Breast tenderness x x x x
Glucose tolerance impaired x x
Dry eye x x
Pituitary haemorrhage x x
Vision blurred x
Vulvovaginal dryness x
Injection site irritation x
Low density lipoprotein increased x x
Body hair loss x x
Hyperuricaemia x
Febrile neutropenia x
Memory loss x
Sleep disorder x
Tumour pain x
Bone density decreased x x
Lupus-like syndrome x
High cholesterol x
Renal impairment x x
Somnolence x x
Vaginal haemorrhage x x
Loss of libido x
Bleeding breakthrough x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

goserelin / ZOLADEX IMPLANT

Side effects:47
Source:medicines.org.au

goserelin / ZOLADEX IMPLANT

Side effects:57
Source:medicines.org.au

goserelin

Side effects:93
Source:BC Cancer

GOSERELIN

Side effects:128
Source:FDA Structured Product Label

GOSERELIN

Side effects:130
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label